An Observational, Multinational, Post-Marketing Registry of Omaveloxolone-Treated Patients With Friedreich's Ataxia
Latest Information Update: 09 Oct 2024
At a glance
- Drugs Omaveloxolone (Primary)
- Indications Friedreich's ataxia
- Focus Adverse reactions
- Sponsors Reata Pharmaceuticals
- 09 Oct 2024 New trial record